Serum Institute of India

ImmunityBio Inc (NASDAQ:IBRX) shares are trading down after an early morning high on Friday after the company announced an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses produced, to supply ImmunityBio with ...

Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the Novavax Inc (NASDAQ: NVAX) vaccine despite diplomatic interventions by India, said an official aware of the development. The delay in receiving raw materials such as bioreactor...

The U.S. will deploy supplies and other assistance to India, the White House said, following a Sunday call between the National Security Advisers (NSA) of two countries, Ajit Doval and Jake Sullivan. What Happened: The assistance includes raw materials for the COVID-19 vaccine, Covishield,...

Serum Institute of India (SII), which has been under pressure, had called on the Indian government for financial support to boost the production of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine. It seems that help is on the way. India is set to accept Serum Institute’...

The European Union has asked India to allow it to buy 10 million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine from Serum Institute of India, a government official told Reuters. What Happened: “The E.U. ambassador wrote a letter, saying, please give...

The World Health Organization (WHO) listed two versions of the AstraZeneca Plc (NASDAQ: AZN) and Oxford University’s COVID-19 vaccine for emergency use, thus widening the access to the shot in the developing countries and boost global supplies in the coming weeks....

Indian conglomerate Tata Sons are in discussion with Moderna Inc (NASDAQ: MRNA) for a partnership with its healthcare unit Tata Medical & Diagnostics, the Economic Times reported on Monday. What Happened: Tata Medical & Diagnostics could team up with the Indian...

A major fire broke out at an under-construction building in the Serum Institute of India (SII) in the city of Pune, Reuters reports. What Happened: A team of the National Disaster Response Force rushed to douse the fire that broke out at 14:45 India time, and the cause of the fire remains...

AstraZeneca Plc’s  (NASDAQ: AZN) partner, the Serum Institute of India, applied for emergency use authorization of the former's COVID-19 vaccine candidate on Sunday, as per the Press Trust Of India. What Happened: The SII is conducting the phase-3 clinical trial of the...

A hundred million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine would be ready for distribution in India by December and an inoculation drive could begin the same month, Bloomberg reported Friday. What Happened: Adar Poonawalla, CEO of  Serum Institute of India Ltd — a...

AstraZeneca plc (NYSE: AZN) COVID-19 vaccine clinical trial is set to resume in India after local partner Serum Institute of India received the go-ahead from Indian regulators, Reuters reported Wednesday. What Happened: The Drugs Controller General of India has approved the trial of the...

Novavax, Inc (NASDAQ: NVAX) disclosed Wednesday it had entered into an agreement with the Serum Institute of India Private Limited for development, distribution, and commercialization of its COVID-19 vaccine in several countries. What Happened SII will gain exclusive rights to Maryland-based...